Fairmount Partners Advises CDMO Pyramid Laboratories in Deal with Audax

Costa Mesa, CA – April 18, 2023 – Audax Private Equity (“Audax”), a leading alternative investment manager and capital partner, announced today that it has made a growth investment in Pyramid Laboratories, Inc. (“Pyramid” or the “Company”) to support the continued growth of the Company’s clinical and commercial biologics and advanced therapeutics manufacturing and service […]

Fairmount Partners Advises The MYND Group Sale to Fingerpaint Group

New York – April 5, 2023 – Fingerpaint Group, an integrated collective of healthcare companies that offer commercialization solutions spanning the full product life cycle, is bolstering its market access offering with the acquisition of The MYND Group, a full-service strategic market access marketing company with extensive healthcare industry expertise in pharmaceuticals and biologics. Details […]

Fairmount Partners Advises CROMSOURCE in its Acquisition by ClinChoice

Philadelphia, PA; Shanghai, China; and Verona, Italy – March 9, 2023 – ClinChoice Medical Development is pleased to announce its acquisition of CROMSOURCE S.r.l., an ISO-certified full-service contract research organization with its corporate headquarters in Verona, Italy and its US headquarters in Cary, NC.  CROMSOURCE has operational subsidiaries in the US and seven countries throughout […]

Fairmount Partners Advises WorkLLama in Capital Raise to Accelerate Growth in Direct Sourcing and Talent Relationship Management

February 28, 2023 – WorkLLama, technology provider of an AI-driven, talent marketing, relationship management, and direct sourcing suite, today announced it has secured $50 million in investments, an indication of the market’s demand for modern technology to access highly skilled, on-demand talent at scale. With the new funds in place, WorkLLama will continue growing its […]

Fairmount Partners Advises Acsel Health in its Acquisition by OPEN Health

London, UK – February 22, 2023 – OPEN Health, a pre-eminent global provider of scientific communications and HEOR & market access services, announced the acquisition of Acsel Health (“Acsel”), a New York-based life science strategy and advisory firm focused on commercial strategy, pricing and market access, and commercial excellence. Acsel’s deep industry expertise, scientific rigor, and actionable analysis drives […]

Fairmount Partners Advises BlueprintNYC in Completing Deal with Eureka Equity Partners

Philadelphia, PA – February 17, 2023 – Eureka Equity Partners (“Eureka”) announced the recapitalization of BlueprintNYC in partnership with Blueprint’s founders and senior team leaders. Blueprint is a leading healthcare engagement agency that provides meeting and event production, training, experiential marketing, and strategic communications services to innovative pharmaceutical manufacturers and biotech companies. Founded in 2012 […]

Fairmount Partners Advises Quire in Securing Investment from SSM Partners

Doylestown, PA – January 17, 2023 – Quire, the best-in-class technical report writing platform, announced today a significant growth investment from SSM Partners, a Memphis-based growth equity firm with extensive experience partnering with and scaling innovative technology businesses. The additional capital will enable Quire to elevate its report writing platform by accelerating its investment in […]

Fairmount Partners Advises EastHORN Clinical Services in its Acquisition by Novotech

Sydney, Australia – January 10, 2023 – Novotech, the leading Asia-Pacific biotech specialist CRO, announced today the acquisition of EastHORN Clinical Services (“EastHORN”), a European CRO with clinical, medical and regulatory expertise in multiple strategically important locations across the continent. The acquisition is part of Novotech’s global expansion program. EastHORN was established in 2004 and […]

Fairmount Partners Advises Charles River Laboratories in the Sale of its Avian Vaccine Services Business to Arlington Capital Partners

WASHINGTON, DC – January 6, 2023 – Arlington Capital Partners (“Arlington”), a Washington, DC-area private equity firm, announced today it has acquired Charles River Laboratories’ (NYSE:CRL) Avian Vaccine Services business to form a new company, AVS Bio (the “Company”). The Company will operate independently as a standalone platform for Arlington that will serve the biologic […]

Fairmount Partners Advises Porzio, Bromberg & Newman in the Acquisition of its Industry-Leading Compliance Software Business, Porzio Life Sciences, by RLDatix

CHICAGO, IL – November 1, 2022 – RLDatix, the leading global provider of healthcare operations software and services that drive safer care, has acquired Porzio Life Sciences, the pioneer and preeminent provider of comprehensive compliance and risk management SaaS products to the life sciences industry.  Porzio Life Sciences had been a wholly-owned subsidiary of the […]